Genetic polymorphisms of drug-metabolizing enzymes and the susceptibility to antituberculosis drug-induced liver injury.
about
Drug-induced hepatotoxicity: metabolic, genetic and immunological basisThe incidence of liver injury in Uyghur patients treated for TB in Xinjiang Uyghur autonomous region, China, and its association with hepatic enzyme polymorphisms nat2, cyp2e1, gstm1 and gstt1Meta-Analysis-Based Preliminary Exploration of the Connection between ATDILI and Schizophrenia by GSTM1/T1 Gene PolymorphismsIdiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicitySuperoxide Dismutase Gene (SOD1, SOD2, and SOD3) Polymorphisms and Antituberculosis Drug-induced Hepatitis.Five-aminosalicylic Acid: an update for the reappraisal of an old drugRisk factors for idiosyncratic drug-induced liver injury.Pharmacogenetics of isoniazid-induced hepatotoxicity.Genome-wide association and replication study of anti-tuberculosis drugs-induced liver toxicity.Role of biotransformation in drug-induced toxicity: influence of intra- and inter-species differences in drug metabolism.Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases.Pharmacogenetics of drug-induced liver injury.Clinical experience of QuantiFERON(®) -TB Gold testing in patients with psoriasis treated with tumour necrosis factor blockers in Taiwan.GSTM1 and GSTT1 genetic polymorphisms and risk of anti-tuberculosis drug-induced hepatotoxicity: an updated meta-analysis.Idiosyncratic drug-induced liver injury: an update on the 2007 overview.Key factors of susceptibility to anti-tuberculosis drug-induced hepatotoxicity.ABCC2 Haplotype is Associated With Antituberculosis Drug-Induced Maculopapular Eruption.NAT2 and CYP2E1 polymorphisms associated with antituberculosis drug-induced hepatotoxicity in Chinese patients.
P2860
Q26991809-67C34F38-25EE-4D5F-8768-C31C9971E25EQ28539060-1062C636-938E-41D7-A2AA-405D1E7FBFA7Q28547892-11200675-3F4C-491B-917B-188A564E4D4FQ34200596-84406C21-3255-4E1B-B6CC-B720B53DF17EQ34760618-5F906C2F-CAE9-48E0-AA63-18CE53CC41A3Q35061210-466B5F10-70D3-4905-A4A0-F91E8568248DQ35168108-F8CD0B14-F815-4143-B1D6-DB2C28726233Q35669887-302ADF89-1124-4E80-9571-8930A82199B7Q36145491-B2FF5A9B-32CD-4411-BC2B-ED9D761F93F8Q36362377-E80FBE0D-B985-4740-884C-2A61688292CBQ37424784-3B3F31DD-499D-4D7C-82CC-B61237896EA9Q37770487-8865D495-AB19-4155-B658-DB1616CBE3F6Q37810305-14C7C372-4D4A-40D1-B882-8580684E0272Q38078780-AA42D685-DB91-4237-BB1A-BFF88BC861B7Q38145274-956DA03A-301D-4EF1-8EAF-18B46EA017C6Q38360770-72DC9897-2777-43AD-A074-FD90F463FB47Q42025168-9B6905F3-1D84-469C-AE9D-71B38F8E4578Q54314510-987142FC-6749-41A8-A3B3-30328E81C9A1
P2860
Genetic polymorphisms of drug-metabolizing enzymes and the susceptibility to antituberculosis drug-induced liver injury.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Genetic polymorphisms of drug- ...... sis drug-induced liver injury.
@ast
Genetic polymorphisms of drug- ...... sis drug-induced liver injury.
@en
type
label
Genetic polymorphisms of drug- ...... sis drug-induced liver injury.
@ast
Genetic polymorphisms of drug- ...... sis drug-induced liver injury.
@en
prefLabel
Genetic polymorphisms of drug- ...... sis drug-induced liver injury.
@ast
Genetic polymorphisms of drug- ...... sis drug-induced liver injury.
@en
P2860
P356
P1476
Genetic polymorphisms of drug- ...... sis drug-induced liver injury.
@en
P2093
Yi-Shin Huang
P2860
P356
10.1517/17425255.3.1.1
P407
P577
2007-02-01T00:00:00Z